Cytokinetics, Inc. (CYTK) Posts Q1 Loss of 27c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.13 --0%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8 million versus the consensus estimate of $7.69 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Cloudastructure reports 164% subscription revenue growth in Q2 2026
- L3Harris names Sam Mehta CEO after Kubasik exits over conduct issues
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
